Details of the Drug Reposition

General Information of This Drug (ID: DMTO9VF)

• Drug Name: Anti-CD22-CAR-transduced T cells (DMTO9VF)
• Drug Type: CAR T Cell Therapy

Information on Drug Reposition of This Drug

2 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
leukaemia	DISS7D1V	2A60-2B33	Phase 1/2	[1]
Lymphoma	DISN6V4S	2A80-2A86	Phase 1/2	[1]

References

• [1] ClinicalTrials.gov (NCT03262298) Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies